Global Vigabatrin Market Growth 2023-2029

February 2023 | 104 pages | ID: GDCB0DCBD183EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Vigabatrin is a medication used to treat epilepsy. It became available as a generic medication in 2019. It works by inhibiting the breakdown of ?-aminobutyric acid (GABA). It is also known as ?-vinyl-GABA, and is a structural analogue of GABA, but does not bind to GABA receptors.

LPI (LP Information)' newest research report, the “Vigabatrin Industry Forecast” looks at past sales and reviews total world Vigabatrin sales in 2022, providing a comprehensive analysis by region and market sector of projected Vigabatrin sales for 2023 through 2029. With Vigabatrin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vigabatrin industry.

This Insight Report provides a comprehensive analysis of the global Vigabatrin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vigabatrin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vigabatrin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vigabatrin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vigabatrin.

The global Vigabatrin market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Vigabatrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Vigabatrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Vigabatrin is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Vigabatrin players cover Sanofi, Benta Pharma Industries, Dr. Fisher Farma, Lundbeck, Novartis, Perrigo, Grindeks, Endo International and Amneal Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Vigabatrin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Tablet
• Powder

Segmentation by application

• Infantile Spasms (IS)
• Partial-Onset Seizures
• Refractory Complex Partial Seizures

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Sanofi
• Benta Pharma Industries
• Dr. Fisher Farma
• Lundbeck
• Novartis
• Perrigo
• Grindeks
• Endo International
• Amneal Pharma
• Cipla
• Upsher-Smith

Key Questions Addressed in this Report

What is the 10-year outlook for the global Vigabatrin market?

What factors are driving Vigabatrin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Vigabatrin market opportunities vary by end market size?

How does Vigabatrin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Vigabatrin Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Vigabatrin by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Vigabatrin by Country/Region, 2018, 2022 & 2029
2.2 Vigabatrin Segment by Type
  2.2.1 Tablet
  2.2.2 Powder
2.3 Vigabatrin Sales by Type
  2.3.1 Global Vigabatrin Sales Market Share by Type (2018-2023)
  2.3.2 Global Vigabatrin Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Vigabatrin Sale Price by Type (2018-2023)
2.4 Vigabatrin Segment by Application
  2.4.1 Infantile Spasms (IS)
  2.4.2 Partial-Onset Seizures
  2.4.3 Refractory Complex Partial Seizures
2.5 Vigabatrin Sales by Application
  2.5.1 Global Vigabatrin Sale Market Share by Application (2018-2023)
  2.5.2 Global Vigabatrin Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Vigabatrin Sale Price by Application (2018-2023)

3 GLOBAL VIGABATRIN BY COMPANY

3.1 Global Vigabatrin Breakdown Data by Company
  3.1.1 Global Vigabatrin Annual Sales by Company (2018-2023)
  3.1.2 Global Vigabatrin Sales Market Share by Company (2018-2023)
3.2 Global Vigabatrin Annual Revenue by Company (2018-2023)
  3.2.1 Global Vigabatrin Revenue by Company (2018-2023)
  3.2.2 Global Vigabatrin Revenue Market Share by Company (2018-2023)
3.3 Global Vigabatrin Sale Price by Company
3.4 Key Manufacturers Vigabatrin Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Vigabatrin Product Location Distribution
  3.4.2 Players Vigabatrin Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR VIGABATRIN BY GEOGRAPHIC REGION

4.1 World Historic Vigabatrin Market Size by Geographic Region (2018-2023)
  4.1.1 Global Vigabatrin Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Vigabatrin Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vigabatrin Market Size by Country/Region (2018-2023)
  4.2.1 Global Vigabatrin Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Vigabatrin Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vigabatrin Sales Growth
4.4 APAC Vigabatrin Sales Growth
4.5 Europe Vigabatrin Sales Growth
4.6 Middle East & Africa Vigabatrin Sales Growth

5 AMERICAS

5.1 Americas Vigabatrin Sales by Country
  5.1.1 Americas Vigabatrin Sales by Country (2018-2023)
  5.1.2 Americas Vigabatrin Revenue by Country (2018-2023)
5.2 Americas Vigabatrin Sales by Type
5.3 Americas Vigabatrin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Vigabatrin Sales by Region
  6.1.1 APAC Vigabatrin Sales by Region (2018-2023)
  6.1.2 APAC Vigabatrin Revenue by Region (2018-2023)
6.2 APAC Vigabatrin Sales by Type
6.3 APAC Vigabatrin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Vigabatrin by Country
  7.1.1 Europe Vigabatrin Sales by Country (2018-2023)
  7.1.2 Europe Vigabatrin Revenue by Country (2018-2023)
7.2 Europe Vigabatrin Sales by Type
7.3 Europe Vigabatrin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Vigabatrin by Country
  8.1.1 Middle East & Africa Vigabatrin Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Vigabatrin Revenue by Country (2018-2023)
8.2 Middle East & Africa Vigabatrin Sales by Type
8.3 Middle East & Africa Vigabatrin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vigabatrin
10.3 Manufacturing Process Analysis of Vigabatrin
10.4 Industry Chain Structure of Vigabatrin

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Vigabatrin Distributors
11.3 Vigabatrin Customer

12 WORLD FORECAST REVIEW FOR VIGABATRIN BY GEOGRAPHIC REGION

12.1 Global Vigabatrin Market Size Forecast by Region
  12.1.1 Global Vigabatrin Forecast by Region (2024-2029)
  12.1.2 Global Vigabatrin Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vigabatrin Forecast by Type
12.7 Global Vigabatrin Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Vigabatrin Product Portfolios and Specifications
  13.1.3 Sanofi Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 Benta Pharma Industries
  13.2.1 Benta Pharma Industries Company Information
  13.2.2 Benta Pharma Industries Vigabatrin Product Portfolios and Specifications
  13.2.3 Benta Pharma Industries Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Benta Pharma Industries Main Business Overview
  13.2.5 Benta Pharma Industries Latest Developments
13.3 Dr. Fisher Farma
  13.3.1 Dr. Fisher Farma Company Information
  13.3.2 Dr. Fisher Farma Vigabatrin Product Portfolios and Specifications
  13.3.3 Dr. Fisher Farma Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Dr. Fisher Farma Main Business Overview
  13.3.5 Dr. Fisher Farma Latest Developments
13.4 Lundbeck
  13.4.1 Lundbeck Company Information
  13.4.2 Lundbeck Vigabatrin Product Portfolios and Specifications
  13.4.3 Lundbeck Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Lundbeck Main Business Overview
  13.4.5 Lundbeck Latest Developments
13.5 Novartis
  13.5.1 Novartis Company Information
  13.5.2 Novartis Vigabatrin Product Portfolios and Specifications
  13.5.3 Novartis Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Novartis Main Business Overview
  13.5.5 Novartis Latest Developments
13.6 Perrigo
  13.6.1 Perrigo Company Information
  13.6.2 Perrigo Vigabatrin Product Portfolios and Specifications
  13.6.3 Perrigo Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Perrigo Main Business Overview
  13.6.5 Perrigo Latest Developments
13.7 Grindeks
  13.7.1 Grindeks Company Information
  13.7.2 Grindeks Vigabatrin Product Portfolios and Specifications
  13.7.3 Grindeks Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Grindeks Main Business Overview
  13.7.5 Grindeks Latest Developments
13.8 Endo International
  13.8.1 Endo International Company Information
  13.8.2 Endo International Vigabatrin Product Portfolios and Specifications
  13.8.3 Endo International Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Endo International Main Business Overview
  13.8.5 Endo International Latest Developments
13.9 Amneal Pharma
  13.9.1 Amneal Pharma Company Information
  13.9.2 Amneal Pharma Vigabatrin Product Portfolios and Specifications
  13.9.3 Amneal Pharma Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Amneal Pharma Main Business Overview
  13.9.5 Amneal Pharma Latest Developments
13.10 Cipla
  13.10.1 Cipla Company Information
  13.10.2 Cipla Vigabatrin Product Portfolios and Specifications
  13.10.3 Cipla Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Cipla Main Business Overview
  13.10.5 Cipla Latest Developments
13.11 Upsher-Smith
  13.11.1 Upsher-Smith Company Information
  13.11.2 Upsher-Smith Vigabatrin Product Portfolios and Specifications
  13.11.3 Upsher-Smith Vigabatrin Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Upsher-Smith Main Business Overview
  13.11.5 Upsher-Smith Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Vigabatrin Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Vigabatrin Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Powder
Table 5. Global Vigabatrin Sales by Type (2018-2023) & (K Units)
Table 6. Global Vigabatrin Sales Market Share by Type (2018-2023)
Table 7. Global Vigabatrin Revenue by Type (2018-2023) & ($ million)
Table 8. Global Vigabatrin Revenue Market Share by Type (2018-2023)
Table 9. Global Vigabatrin Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Vigabatrin Sales by Application (2018-2023) & (K Units)
Table 11. Global Vigabatrin Sales Market Share by Application (2018-2023)
Table 12. Global Vigabatrin Revenue by Application (2018-2023)
Table 13. Global Vigabatrin Revenue Market Share by Application (2018-2023)
Table 14. Global Vigabatrin Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Vigabatrin Sales by Company (2018-2023) & (K Units)
Table 16. Global Vigabatrin Sales Market Share by Company (2018-2023)
Table 17. Global Vigabatrin Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Vigabatrin Revenue Market Share by Company (2018-2023)
Table 19. Global Vigabatrin Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Vigabatrin Producing Area Distribution and Sales Area
Table 21. Players Vigabatrin Products Offered
Table 22. Vigabatrin Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Vigabatrin Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Vigabatrin Sales Market Share Geographic Region (2018-2023)
Table 27. Global Vigabatrin Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Vigabatrin Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Vigabatrin Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Vigabatrin Sales Market Share by Country/Region (2018-2023)
Table 31. Global Vigabatrin Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Vigabatrin Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Vigabatrin Sales by Country (2018-2023) & (K Units)
Table 34. Americas Vigabatrin Sales Market Share by Country (2018-2023)
Table 35. Americas Vigabatrin Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Vigabatrin Revenue Market Share by Country (2018-2023)
Table 37. Americas Vigabatrin Sales by Type (2018-2023) & (K Units)
Table 38. Americas Vigabatrin Sales by Application (2018-2023) & (K Units)
Table 39. APAC Vigabatrin Sales by Region (2018-2023) & (K Units)
Table 40. APAC Vigabatrin Sales Market Share by Region (2018-2023)
Table 41. APAC Vigabatrin Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Vigabatrin Revenue Market Share by Region (2018-2023)
Table 43. APAC Vigabatrin Sales by Type (2018-2023) & (K Units)
Table 44. APAC Vigabatrin Sales by Application (2018-2023) & (K Units)
Table 45. Europe Vigabatrin Sales by Country (2018-2023) & (K Units)
Table 46. Europe Vigabatrin Sales Market Share by Country (2018-2023)
Table 47. Europe Vigabatrin Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Vigabatrin Revenue Market Share by Country (2018-2023)
Table 49. Europe Vigabatrin Sales by Type (2018-2023) & (K Units)
Table 50. Europe Vigabatrin Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Vigabatrin Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Vigabatrin Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Vigabatrin Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Vigabatrin Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Vigabatrin Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Vigabatrin Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Vigabatrin
Table 58. Key Market Challenges & Risks of Vigabatrin
Table 59. Key Industry Trends of Vigabatrin
Table 60. Vigabatrin Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Vigabatrin Distributors List
Table 63. Vigabatrin Customer List
Table 64. Global Vigabatrin Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Vigabatrin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Vigabatrin Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Vigabatrin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Vigabatrin Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Vigabatrin Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Vigabatrin Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Vigabatrin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Vigabatrin Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Vigabatrin Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Vigabatrin Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Vigabatrin Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Vigabatrin Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Vigabatrin Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Sanofi Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 79. Sanofi Vigabatrin Product Portfolios and Specifications
Table 80. Sanofi Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Sanofi Main Business
Table 82. Sanofi Latest Developments
Table 83. Benta Pharma Industries Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 84. Benta Pharma Industries Vigabatrin Product Portfolios and Specifications
Table 85. Benta Pharma Industries Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Benta Pharma Industries Main Business
Table 87. Benta Pharma Industries Latest Developments
Table 88. Dr. Fisher Farma Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 89. Dr. Fisher Farma Vigabatrin Product Portfolios and Specifications
Table 90. Dr. Fisher Farma Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Dr. Fisher Farma Main Business
Table 92. Dr. Fisher Farma Latest Developments
Table 93. Lundbeck Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 94. Lundbeck Vigabatrin Product Portfolios and Specifications
Table 95. Lundbeck Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lundbeck Main Business
Table 97. Lundbeck Latest Developments
Table 98. Novartis Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Vigabatrin Product Portfolios and Specifications
Table 100. Novartis Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Perrigo Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 104. Perrigo Vigabatrin Product Portfolios and Specifications
Table 105. Perrigo Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Perrigo Main Business
Table 107. Perrigo Latest Developments
Table 108. Grindeks Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 109. Grindeks Vigabatrin Product Portfolios and Specifications
Table 110. Grindeks Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Grindeks Main Business
Table 112. Grindeks Latest Developments
Table 113. Endo International Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 114. Endo International Vigabatrin Product Portfolios and Specifications
Table 115. Endo International Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Endo International Main Business
Table 117. Endo International Latest Developments
Table 118. Amneal Pharma Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 119. Amneal Pharma Vigabatrin Product Portfolios and Specifications
Table 120. Amneal Pharma Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Amneal Pharma Main Business
Table 122. Amneal Pharma Latest Developments
Table 123. Cipla Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 124. Cipla Vigabatrin Product Portfolios and Specifications
Table 125. Cipla Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Cipla Main Business
Table 127. Cipla Latest Developments
Table 128. Upsher-Smith Basic Information, Vigabatrin Manufacturing Base, Sales Area and Its Competitors
Table 129. Upsher-Smith Vigabatrin Product Portfolios and Specifications
Table 130. Upsher-Smith Vigabatrin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Upsher-Smith Main Business
Table 132. Upsher-Smith Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Vigabatrin
Figure 2. Vigabatrin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vigabatrin Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Vigabatrin Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Vigabatrin Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Powder
Figure 11. Global Vigabatrin Sales Market Share by Type in 2022
Figure 12. Global Vigabatrin Revenue Market Share by Type (2018-2023)
Figure 13. Vigabatrin Consumed in Infantile Spasms (IS)
Figure 14. Global Vigabatrin Market: Infantile Spasms (IS) (2018-2023) & (K Units)
Figure 15. Vigabatrin Consumed in Partial-Onset Seizures
Figure 16. Global Vigabatrin Market: Partial-Onset Seizures (2018-2023) & (K Units)
Figure 17. Vigabatrin Consumed in Refractory Complex Partial Seizures
Figure 18. Global Vigabatrin Market: Refractory Complex Partial Seizures (2018-2023) & (K Units)
Figure 19. Global Vigabatrin Sales Market Share by Application (2022)
Figure 20. Global Vigabatrin Revenue Market Share by Application in 2022
Figure 21. Vigabatrin Sales Market by Company in 2022 (K Units)
Figure 22. Global Vigabatrin Sales Market Share by Company in 2022
Figure 23. Vigabatrin Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Vigabatrin Revenue Market Share by Company in 2022
Figure 25. Global Vigabatrin Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Vigabatrin Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Vigabatrin Sales 2018-2023 (K Units)
Figure 28. Americas Vigabatrin Revenue 2018-2023 ($ Millions)
Figure 29. APAC Vigabatrin Sales 2018-2023 (K Units)
Figure 30. APAC Vigabatrin Revenue 2018-2023 ($ Millions)
Figure 31. Europe Vigabatrin Sales 2018-2023 (K Units)
Figure 32. Europe Vigabatrin Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Vigabatrin Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Vigabatrin Revenue 2018-2023 ($ Millions)
Figure 35. Americas Vigabatrin Sales Market Share by Country in 2022
Figure 36. Americas Vigabatrin Revenue Market Share by Country in 2022
Figure 37. Americas Vigabatrin Sales Market Share by Type (2018-2023)
Figure 38. Americas Vigabatrin Sales Market Share by Application (2018-2023)
Figure 39. United States Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Vigabatrin Sales Market Share by Region in 2022
Figure 44. APAC Vigabatrin Revenue Market Share by Regions in 2022
Figure 45. APAC Vigabatrin Sales Market Share by Type (2018-2023)
Figure 46. APAC Vigabatrin Sales Market Share by Application (2018-2023)
Figure 47. China Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Vigabatrin Sales Market Share by Country in 2022
Figure 55. Europe Vigabatrin Revenue Market Share by Country in 2022
Figure 56. Europe Vigabatrin Sales Market Share by Type (2018-2023)
Figure 57. Europe Vigabatrin Sales Market Share by Application (2018-2023)
Figure 58. Germany Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Vigabatrin Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Vigabatrin Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Vigabatrin Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Vigabatrin Sales Market Share by Application (2018-2023)
Figure 67. Egypt Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Vigabatrin Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Vigabatrin in 2022
Figure 73. Manufacturing Process Analysis of Vigabatrin
Figure 74. Industry Chain Structure of Vigabatrin
Figure 75. Channels of Distribution
Figure 76. Global Vigabatrin Sales Market Forecast by Region (2024-2029)
Figure 77. Global Vigabatrin Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Vigabatrin Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Vigabatrin Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Vigabatrin Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Vigabatrin Revenue Market Share Forecast by Application (2024-2029)